ECHO Administrative Supplement - Neonatal Opioid Trials

Information

  • Research Project
  • 10459783
  • ApplicationId
    10459783
  • Core Project Number
    U2COD023375
  • Full Project Number
    3U2COD023375-06S1
  • Serial Number
    023375
  • FOA Number
    PA-20-272
  • Sub Project Id
  • Project Start Date
    9/21/2016 - 8 years ago
  • Project End Date
    8/31/2023 - a year ago
  • Program Officer Name
    BLAISDELL, CAROL J
  • Budget Start Date
    9/14/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    06
  • Suffix
    S1
  • Award Notice Date
    9/14/2021 - 3 years ago
Organizations

ECHO Administrative Supplement - Neonatal Opioid Trials

Neonatal opioid withdrawal syndrome (NOWS) has increased more than fivefold since 2000. The dramatic rise in NOWS has occurred in association with an increase in the use of opioids by pregnant women. Little is known about the best methods for identification, monitoring, and treatment of affected infants. The IDeA States Pediatric Clinical Trials Network (ISPCTN), which is part of the Environmental influences on Child Health Outcomes (ECHO) Program, and the Neonatal Research Network (NRN) are uniquely poised to address existing knowledge gaps associated with NOWS. The ISPCTN consists of >20 neonatal intensive care units and the NRN consists of >50 neonatal intensive care units. Both networks have access to investigators, study coordinators, infrastructure, and participants for clinical trials. The Duke Clinical Research Institute (DCRI) serves as the ECHO Coordinating Center and has extensive experience in cohort studies and clinical trials in infants. We will also leverage the expertise of the Data Coordinating and Operations Center (DCOC) of the ISPCTN at the University of Arkansas for Medical Sciences (UAMS). The overall goal of our proposal is to use the infrastructure of the ECHO Program and ISPCTN in collaboration with the NRN to initiate two clinical trials to evaluate interventions to improve the care of infants and families affected by NOWS. Our research team, led by Drs. Brian Smith and Rachel Greenberg at DCRI and Drs. Jeannette Lee and Jessica Snowden at UAMS, will achieve this goal by implementing: 1) a clinical trial protocol evaluating the optimal use of the Eating, Sleeping, Consoling (ESC) care approach on the length of time until infants affected by NOWS are medically ready for discharge; and 2) a clinical trial protocol evaluating whether an early stop weaning protocol for morphine in infants treated for NOWS will decrease the number of days of opioid treatment. Using the highest research standards, we will accomplish the task set out by the NIH to close research gaps in this critically important area. 1 2

IC Name
OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH
  • Activity
    U2C
  • Administering IC
    OD
  • Application Type
    3
  • Direct Cost Amount
    4999808
  • Indirect Cost Amount
    789983
  • Total Cost
    1500000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    310
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NINDS:1500000\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    DUKE UNIVERSITY
  • Organization Department
    PEDIATRICS
  • Organization DUNS
    044387793
  • Organization City
    DURHAM
  • Organization State
    NC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    277054673
  • Organization District
    UNITED STATES